CHAMPIONS ONCOLOGY INC (CSBR)
US15870P3073 - Common Stock
| MRQ (2024-1-31) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.47M | 10.12M | 9.01M | 4.69M | 8.34M | |||
| Receivables | 7.89M | 8.01M | 9.51M | 6.99M | 4.77M | |||
| Other Current Assets | 835.00K | 1.33M | 1.14M | 960.00K | 390.00K | |||
| Total Current Assets | 13.20M | 19.46M | 19.66M | 12.63M | 13.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.07M | 14.50M | 15.36M | 14.61M | 6.79M | |||
| Goodwill | 335.00K | 340.00K | 340.00K | 340.00K | 340.00K | |||
| Other Non-Current Assets | 185.00K | 20.00K | 20.00K | 20.00K | 130.00K | |||
| Total Non-Current Assets | 13.59M | 14.85M | 15.72M | 14.96M | 7.25M | |||
| TOTAL ASSETS | 26.79M | 34.31M | 35.38M | 27.59M | 20.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 1.05M | 0.00 | 130.00K | |||
| Accrued Expenses | 3.73M | 3.48M | 3.47M | 3.05M | 3.01M | |||
| Accounts Payable | 4.76M | 5.33M | 2.87M | 1.89M | 3.14M | |||
| Other Current Liabilities | 13.48M | 12.92M | 11.14M | 6.26M | 5.82M | |||
| Total Current Liabilities | 21.97M | 21.73M | 17.48M | 11.20M | 12.09M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.88M | 7.94M | 8.80M | 8.96M | 3.35M | |||
| Total Non-Current Liabilities | 6.88M | 7.95M | 8.80M | 8.96M | 3.34M | |||
| TOTAL LIABILITIES | 28.84M | 29.68M | 26.28M | 20.16M | 15.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -84.48M | -77.32M | -71.98M | -72.53M | -72.67M | |||
| Additional Paid In Capital | 83.12M | 82.01M | 81.06M | 79.95M | 77.98M | |||
| Common Shares | 14.00K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Treasury Stock | -708.00K | -70.00K | N/A | N/A | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 7.43M | N/A | |||
| Shares Outstanding | 13.59M | 13.54M | 13.52M | 13.41M | 12.73M | |||
| Tangible Book Value per Share | -0.18 | 0.32 | 0.65 | 0.53 | 0.39 | |||
| Total Shareholders' Equity | -2.06M | 4.64M | 9.10M | 7.43M | 5.32M | |||
| TOTAL LIABILITIES AND EQUITY | 26.79M | 34.31M | 35.38M | 27.59M | 20.75M | |||
| Statistics | ||||||||
| Current Ratio | 0.60 | 0.90 | 1.12 | 1.13 | 1.12 | |||
| Return On Assets (ROA) | -36.33% | -15.56% | 1.55% | 1.30% | -9.54% | |||
| Return On Equity (ROE) | N/A | -115.09% | 6.04% | 4.85% | -37.22% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 2.69% | 1.78% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 5.42% | 2.50% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 5.64% | 2.57% | N/A | |||
All data in USD